James M. Mock - 03 Oct 2025 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role: Chief Financial Officer
Signature: /s/ James Dillon, As Attorney-in-Fact
Issuer symbol: MRNA
Transactions as of: 03 Oct 2025
Net transactions value: -$19,944
Form type: 4
Filing time: 06 Oct 2025, 16:23:23 UTC
Previous filing: 29 Aug 2025
Next filing: 01 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Mock James M	Chief Financial Officer	C/O MODERNA, INC., 325 BINNEY STREET, CAMBRIDGE	/s/ James Dillon, As Attorney-in-Fact	06 Oct 2025	0001736359

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRNA	Common Stock	Options Exercise		+1,453	+8.3%		18,962	03 Oct 2025	Direct	F1
transaction	MRNA	Common Stock	Tax liability	$19,944	-703	-3.7%	$28.37	18,259	03 Oct 2025	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRNA	Restricted Stock Units	Options Exercise	$0	-1,453	-20%	$0.000000	5,811	03 Oct 2025	Common Stock	1,453		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert into common stock on a one-for-one basis.
F2	Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
F3	25% of the shares subject to this restricted stock unit award vested on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.